EP3383392
DOSING REGIMENS FOR 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
2.12.2016EP published:
9.7.2025EP application number:
16813299.1
EPO information:
European Patent Register
Max expiry date:
1.12.2036
Title in English:
DOSING REGIMENS FOR 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDELanguage of the patent:
English
Timeline
Today
2.12.2016EP application
9.7.2025EP Publication
Owner
Name:
Global Blood Therapeutics, Inc.Address:
181 Oyster Point Blvd., South San Francisco, CA 94080, US
Inventor
Name:
RAMOS, Eleanor, L.Address:
South San Francisco, CA 94080, US
Name:
LEHRER-GRAIWER, Joshua, EliAddress:
South San Francisco, CA 94080, US
Name:
HUTCHALEELAHA, AthiwatAddress:
South San Francisco, CA 94080, US
Name:
BEJUGAM, NaveenAddress:
South San Francisco, CA 94080, US
Priority
Number:
201562263554 PDate:
4.12.2015Country:
US
Number:
201662375832 PDate:
16.8.2016Country:
US
Classification
Categories:
A61K 31/4439, A61K 9/48, A61P 35/02